# FITLIFE BRANDS, INC. (FTLF) · Edgar & Edgarette company card

> Fitlife Brands (FTLF) grew revenue 26.4% in FY2025 to $81 million, operating margin 12.4% against a 0.7% median for medicinal chemicals & botanical products, equity 41.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1374328 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/FTLF) · [JSON](https://www.pops4.com/boards/company/FTLF.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $81M |
| Revenue growth, 1 year | 26.4% |
| Revenue growth per year | 30.7% |
| Operating margin | 12.4% (prior year 20.3%) |
| Net margin | 7.8% |
| Operating cash flow | $7M |
| Capital spending | $42,000 |
| Free cash flow | $7M |
| Cash | — |
| Long-term debt | — |
| Total assets | $106M |
| Total equity | $44M |
| Equity ÷ assets | 41.0% |
| Return on equity | 14.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 2.44 (grey zone)
- Piotroski F: 3 of 9 (middling)
- Beneish M: 0.86 (above the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; revenue is hard to predict: its 80% range is ±39%
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $81.5M (FY2025). Experience: revenue up 26.4% on the year, up 30.7% a year over 4 years; operating margin 12.4%, down from 20.3%. Soundness: equity 41.0% of assets, return on equity 14.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $70.0M and $158.5M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $72.2M to $154.0M. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin 12.4% against a 0.7% median; growth 26.4% against 1.7%.

Range logged 2026-09-29, receipt 4539cfe52b154742, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-05-22 ([filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926018249/0001437749-26-018249-index.htm))

## Recent filings

- 8-K · filed 2026-09-09 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926029979/0001437749-26-029979-index.htm)
- 8-K · filed 2026-08-13 · 2.02 Results of Operations and Financial Condition; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926027493/0001437749-26-027493-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926027478/0001437749-26-027478-index.htm)
- DEF 14A · filed 2026-06-26 · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926021797/0001437749-26-021797-index.htm)
- 8-K · filed 2026-05-22 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926018249/0001437749-26-018249-index.htm)
- 8-K · filed 2026-05-14 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1374328/000143774926016983/0001437749-26-016983-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001374328.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1374328

## Cite

POPS4, Edgar & Edgarette: FITLIFE BRANDS, INC. (FTLF) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/FTLF. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.